Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook

StreetInsider2022-02-23

Teladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Chong135
    2022-02-23
    Chong135
    The outlook shows that even the senior management thinks they not gonna grow by a large margin because :1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help2. People's behaviour has not really switched to tele health services muchTherefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.
  • yaozong7
    2022-02-23
    yaozong7
    Poor teladoc. Low can go lower indeed
  • Lavender00
    2022-02-23
    Lavender00
    Q4 EPS -0.07. Thought this is going to be profitable soon. next Q EPS highest estimated -0.50. [Speechless] 
Leave a comment
3